Use of Decametoxinum in bronchiectasis

K. Gashynova (Dnipro, Ukraine), K. Suska (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine)

Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Session: Non-tuberculous mycobacterial infections and bronchiectasis
Session type: E-poster session
Number: 2371
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Gashynova (Dnipro, Ukraine), K. Suska (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine). Use of Decametoxinum in bronchiectasis. 2371

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of bronchiectasis
Source: Breathe 2010; 6: 353-360
Year: 2010

The bronchiectasis ‘bacteriophagome’
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021



Immunodeficits in bronchiectasis
Source: International Congress 2017 – PG3 Bronchiectasis
Year: 2017


Care of adults with cystic fibrosis
Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Year: 2016


Care of adults with cystic fibrosis
Source: International Congress 2016 – Transition to adult care: what we can learn from cystic fibrosis?
Year: 2016


Management of bronchiectasis in adults
Source: Eur Respir J 2015; 45: 1446-1462
Year: 2015



Knowledge and adherence of airway clearance techniques in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Respiratory physiotherapy: outcomes in disease and health
Year: 2015

Use of spirometry for case-finding of obstructive pulmonary disorders in Belgium
Source: Eur Respir J 2007; 30: Suppl. 51, 96s
Year: 2007

Management and prevention of non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – PG9 Lower respiratory tract infection in children
Year: 2015




Late Breaking Abstract - Use of mepolizumab in bronchiectasis with underlying eosinophilic condition
Source: International Congress 2018 – New methods for diagnosing and treating lung diseases
Year: 2018



Use of BIOFIRE® Pneumonia Panel Plus on sputum from patients with Cystic fibrosis or PCD
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Use of antibiotics in children with asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 617s
Year: 2005

The effect of pulmonary rehabilitation on non COPD patients
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014

Use of portable spirometers in a paediatric cystic fibrosis clinic
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021

Use of noninvasive mechanical ventilation in patients with cystic fibrosis
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010


Pneumothorax in treatment of severe emphysema with endobronchial valves
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other
Year: 2014


Diagnosis and management of non-cystic fibrosis bronchiectasis in children
Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment
Year: 2018


Acute exacerbation of bronchiectasis - reality of a Pneumology Department
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019